In order to train artificial intelligence models, OpenAI, Anthropic, and Google have been actively searching for various professional data, and are also negotiating cooperation with startups and listed companies to obtain data set authorization in fields such as genomics. According to some people who have communicated with related companies, in recent months, OpenAI staff have been in contact with a number of companies, including life science diagnostic provider Revvity, accounting software service provider Xero, and many companies in the biotechnology, consumer health, software, and financial services fields to explore the possibility of data licensing or other forms of cooperation. DeepMind founder Zavin Dahl said that at the same time, Anthropic, DeepMind, and Isomorphic Laboratories, an independent company under Google focusing on artificial intelligence drug development, have begun discussions with a number of early-stage biotech startups on data licensing or cooperation.

In order to train artificial intelligence models, OpenAI, Anthropic, and Google have been actively searching for various professional data, and are also negotiating cooperation with startups and listed companies to obtain data set authorization in fields such as genomics. According to some people who have communicated with related companies, in recent months, OpenAI staff have been in contact with a number of companies, including life science diagnostic provider Revvity, accounting software service provider Xero, and many companies in the biotechnology, consumer health, software, and financial services fields to explore the possibility of data licensing or other forms of cooperation. DeepMind founder Zavin Dahl said that at the same time, Anthropic, DeepMind, and Isomorphic Laboratories, an independent company under Google focusing on artificial intelligence drug development, have begun discussions with a number of early-stage biotech startups on data licensing or cooperation.